Sankyo Pharma to Help Outfit U of Buffalo s Pharmacy School With PGx Technologies | GenomeWeb

NEW YORK, April 15 (GenomeWeb News) - Part of a $100,000 grant from Japanese drug maker Sankyo Pharma will go to help the University of Buffalo's School of Pharmacy and Pharmaceutical Sciences to buy "new analytical equipment" for pharmacogenomics research, according to a local media report.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.